Fact CheckerSign in

NCT05672797Completed

Habitual Hypertension Medication Adherence in Arizona

Source: ClinicalTrials.gov · Last updated 2 Aug 2024

Brief summary (registry, in English)

This research will implement a novel habit formation intervention among people living with hypertension and an indication of medication non-adherence to help maintain high anti-hypertensive (AH) medication adherence by leveraging the power of routines and unconsciously triggered habitual behaviors. The investigators will test whether high AH medication adherence can be maintained using contextually-cued medication adherence habits that mitigate the negative effects of declining motivation, forgetfulness, and the cognitive burden of performing repeated daily behaviors. The use of mHealth tools will help to make this a scalable and sustainable intervention approach for addressing an important healthcare issue in Arizona.

Status (registry)
Completed
Study type
Interventional
Enrollment
125 (actual)
First submitted
19 Dec 2022
Start date
12 Dec 2022
Primary completion date
31 Mar 2024
Lead sponsor
Arizona State University
NCT number
NCT05672797

What you commit to

  • Study type: Interventional
  • Participants enrolled: 125
  • From 12 Dec 2022 to the primary completion date, 31 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Has not demonstrated antihypertensive medication nonadherence within the past 12 months

Other illness

  • Does not have current hypertension diagnosis
  • Not currently engaged in hypertension care

Age

  • Less than 18 years old

Other

  • Unable to read/write/understand English
  • Does not have daily access to a smartphone

Who the study is looking for

  • Aged 18 years old or older
  • Currently diagnosed with hypertension (either stage I or stage II hypertension)
  • Able to read/write/understand English
  • Have daily access to a smartphone
  • Engaged in hypertension care (i.e., already been prescribed antihypertensive medication for a minimum of 12 months at the time of study enrollment)
  • Demonstrated antihypertensive medication nonadherence by having over 73 days without documented antihypertensive medication prescription coverage (observable in Arizona Health Care Cost Containment System (AHCCCS) prescription drugs claims) in the past 12 months (i.e., \>80% mean adherence)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Arizona State University
Coordinator of this site? Confirm its status
PhoenixUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.